Improvement in liver pathology after 4 months of D-penicillamine in 5 Doberman Pinschers with subclinical hepatitis

Journal of Veterinary Internal Medicine

Volumn 19, Issue 1, 2005, Pages 40-43

  Mandigers, P J J ^a,c   Van Den Ingh, T S G A M ^a   Bode, P ^b   Rothuizen, J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Copper toxicosis; Dogs; Etiology

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; BILE ACID; CHELATING AGENT; COPPER; CREATININE; PENICILLAMINE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BILE ACID BLOOD LEVEL; BLOOD ANALYSIS; CHELATION; CONTROLLED STUDY; COPPER BLOOD LEVEL; COPPER METABOLISM; CREATININE BLOOD LEVEL; DOG; ERYTHROCYTE COUNT; FEMALE; HEPATITIS; HISTOPATHOLOGY; LEUKOCYTE COUNT; LEUKOCYTE DIFFERENTIAL COUNT; LIVER BIOPSY; LIVER TOXICITY; NONHUMAN; PATHOPHYSIOLOGY; QUANTITATIVE ANALYSIS; THROMBOCYTE COUNT;

ANIMALS; BIOPSY, NEEDLE; CHELATING AGENTS; COPPER; DOG DISEASES; DOGS; FEMALE; HEPATITIS, ANIMAL; LIVER; PENICILLAMINE;

ANIMALIA; CANIS FAMILIARIS;

EID: 7944234275     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2005)19<40:IILPAM>2.0.CO;2     Document Type: Article

References (37)

1. Meyer DJ, Iverson WO, Terrell TG. Obstructive jaundice associated with chronic active hepatitis in a dog. J Am Vet Med Assoc 1980;176:41-44.
2. Johnson GF, Zawie DA, Gilbertson SR, et al. Chronic active hepatitis in Doberman Pinschers. J Am Vet Med Assoc 1982;180:1438-1442.
3. Thornburg LP, Rottinghaus G, Koch J, et al. High liver copper levels in two Doberman Pinschers with subacute hepatitis J Am Anim Hosp Assoc 1983;20:1003-1005.
4. Crawford MA, Schall WD, Jensen RK, et al. Chronic active hepatitis in 26 Doberman Pinschers. J Am Vet Med Assoc 1985;187:1343-1350.
5. Ingh TSGAMvd, Rothuizen J, Cupery R. Chronic active hepatitis with cirrhosis in the Dobermann Pinscher. Vet Q 1988;10:84-89.
6. Speeti M, Ihantola M, Westermarck E. Subclinical versus clinical hepatitis in the Dobermann: Evaluation of changes in blood parameters J Small Anim Pract 1996;37:465-470.
7. Speeti M, Eriksson J, Saari S, et al. Lesions of subclinical Doberman hepatitis. Vet Pathol 1998;35:361-369.
8. Thornburg LP. Histomorphological and immunohistochemical studies of chronic active hepatitis in Doberman Pinschers. Vet Pathol 1998;35:380-385.
9. Speeti M, Eriksson J, Westermarck E. Some new aspects of the role of copper in Doberman hepatitis. Eur J Vet Pathol 1999;5:51-56.
10. Mandigers PJJ, van den Ingh TSGAM, Bode P, et al. Association between liver copper concentration and subclinical hepatitis in Doberman Pinschers. J Vet Intern Med 2004;18:647-650
11. Fuentealba IC, Guest S, Haywood S, et al. Chronic hepatitis: A retrospective study in 34 dogs. Can Vet J 1997;38:365-373.
12. Twedt DC, Sternlieb I, Gilbertson SR. Clinical, morphologic, and chemical studies on copper toxicosis of Bedlington Terriers. J Am Vet Med Assoc 1979;175:269-275.
13. Thornburg LP, Policy D, Dimmi HR. The diagnosis and treatment of copper toxicosis in dogs. Canine Pract 1984;11:36-39.
14. Thornburg LP, Shaw D, Dolan M, et al. Hereditary copper toxicosis in West Highland white terriers. Vet Pathol 1986;23:148-154.
15. Rolfe DS, Twedt DC. Copper-associated hepatopathies in dogs. Vet Clin North Am Small Anim Pract 1995;25:399-417.
16. Walshe JM. Penicillamine: A new oral therapy for Wilson's disease Am J Med 1956;2:487-495.
17. Brewer GJ. Practical recommendations and new therapies for Wilson's disease. Drugs 1995;50:240-249.
18. Lettow E. Lebererkrankungen beim Hund. Tierarztl Prax 1974;2:321-343.
19. Osborne CA, Hardy RM, Stevens JB, et al. Liver biopsy. Vet Clin North Am 1974;4:333-350.
20. Bode P. Automation and quality assurance in the neutron activation facilities in Delft. J Radioanal Nucl Chem 2000;245:127-132.
21. Plumb DC. Veterinary Drug Handbook, 4th ed. Ames, IA: Iowa State University Press; 2002:629-630.
22. Klein D, Lichtmannegger J, Heinzmann U, et al. Dissolution of copper-rich granules in hepatic lysosomes by D-penicillamine prevents the development of fulminant hepatitis in Long-Evans cinnamon rats. J Hepatol 2000;32:193-201.
23. Frommer DJ. Urinary copper excretion and hepatic copper concentrations in liver disease. Digestion 1981;21:169-178.
24. Dastych M, Jezek P, Richtrova M. Effect of penicillamine therapy on the concentration of zinc, copper, iron, calcium and magnesium in the serum and their excretion in urine [in German]. Z Gastroenterol 1986;24:157-160.
25. Walshe JM. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride. Lancet 1982;1:643-647.
26. Brewer GJ, Dick RD, Schall W, et al. Use of zinc acetate to treat copper toxicosis in dogs. J Am Vet Med Assoc 1992;201:564-568.
27. Hardy RM. Chronic hepatitis. An emerging syndrome in dogs. Vet Clin North Am Small Anim Pract 1985;15:135-150.
28. Rothuizen J, Ingh TSGAMvd. Hepatitis in dogs; a review Tijdschr Diergeneeskd 1998;123:246-252.
29. Controlled trial of D(-)penicillamine in severe rheumatoid arthritis. Lancet 1973;1:275-280.
30. Munthe E, Jellum E, Aaseth J. Some aspects of the mechanism of action of penicillamine in rheumatoid arthritis. Scand J Rheumatol Suppl 28 (Suppl):1979;6-12.
31. Scheinberg IH. Copper penicillaminate for rheumatoid arthritis? J Rheumatol Suppl 1981;7:178-179.
32. Jaffe IA. Penicillamine: An anti-rheumatoid drug. Am J Med 1983;75:63-68.
33. Stanworth DR, Hunneyball IM. Influence of D-penicillamine treatment on the humoral immune system. Scand J Rheumatol Suppl 28 (Suppl);1979:37-46.
34. Epstein O, De Villiers D, Jain S, et al. Reduction of immune complexes and immunoglobulins induced by D-penicillamine in primary biliary cirrhosis. N Engl J Med 1979;300:274-278.
35. Harth M, Keown PA, Orange JE Effects of D-penicillamine on inflammatory and immune reactions. Clin Invest Med 1984;7:45-51.
36. Speeti M, Stahls A, Meri S, et al. Upregulation of major histocompatibility complex class II antigens in hepatocytes in Doberman hepatitis. Vet Immunol Immunopathol 2003;96:1-12.
37. Czaja AJ. Treatment of autoimmune hepatitis. Semin Liver Dis 2002;22:365-378.